Anh Singhania

Anh Singhania has over 20 years of experience in the pharmaceutical industry. Their most recent role is Senior Director, Health Systems & Outcomes, Medical Affairs at Intercept Pharmaceuticals, starting in February 2023. Prior to this, Singhania worked as a Senior Director at Turning Point Therapeutics from April 2022 to February 2023. From June 2020 to April 2022, they held the position of Senior Director, HEOR and Medical Publications at Summit Therapeutics. Furthermore, Singhania was a Senior Director, HEOR at Summit Therapeutics from December 2019 to June 2020.

From 2018 to 2019, Singhania served as the Director, Key Account, Market Access at Insmed Incorporated. Prior to that, they worked at ZS Pharma, Inc. (an Astra Zeneca company) as a Medical Science Director-Managed Markets, HEOR from July 2015 to January 2018. Singhania's previous experience includes roles at Daiichi Sankyo as a Principal Health Outcomes Liaison from March 2008 to July 2015, at Takeda as a Clinical & Outcomes Manager from September 2006 to March 2008, at Astellas as a Senior Science Liaison from July 2003 to September 2006, at Yamanouchi as a Clinical Science Liaison from July 2003 to April 2005, and at Novartis as a Health Economics and Outcomes Research Fellow from 2001 to 2003.

Anh Singhania holds a Doctor of Pharmacy degree (PharmD) from the University of Houston. Prior to that, they completed a Bachelor of Science degree (BS) in Microbiology/Pharmacy Administration/HEOR Fellowship from The University of Texas at Austin. The exact start and end years for both degrees are not provided.